Aptose Reports Results for the Fourth Quarter and Full Year 2023
Breadcrumb Trail Links GlobeNewswire Author of the article: Published Mar 26, 2024 • 10 minute read Article content Tuspetinib to Advance to TUS+VEN+HMA Triplet Therapy Pilot Study in 1L AML Tuspetinib Continues Broad Activity Across Mutations with …